The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...
A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...
Study shows diabetes drugs' potential beyond weight loss A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and ...
The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...
Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, ...